Bendamustine, lenalidomide, and dexamethasone (BRD) is highly effective with durable responses in relapsed multiple myeloma

Shaji K. Kumar, Amrita Krishnan, Betsy Laplant, Kristina Laumann, Vivek Roy, Todd Zimmerman, Morie A. Gertz, Francis K. Buadi, Keith Stockerl Goldstein, Ann Birgin, Mark Fiala, Lupe Duarte, Michelle Maharaj, Joan Levy, Ravi Vij

Research output: Contribution to journalArticlepeer-review

12 Scopus citations

Fingerprint

Dive into the research topics of 'Bendamustine, lenalidomide, and dexamethasone (BRD) is highly effective with durable responses in relapsed multiple myeloma'. Together they form a unique fingerprint.

Medicine & Life Sciences